Greg Cavers insider trades: Helus Pharma (HELP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Greg reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | HELP | ↑ Buy | 3,000 | $12.91 | $39K | Held by spouse | Oct 1, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Greg Cavers's insider trades
Greg Cavers is Chief Financial Officer at Helus Pharma (HELP). Since Sep 29, 2026, Greg has reported 1 open-market purchase worth $39K and no sales on SEC Form 4. In the last 12 months: 1 buy ($39K).
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HELP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.